Seoul, South Korea

Yun Taek Jung


Average Co-Inventor Count = 11.1

ph-index = 4

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Yun Taek Jung

Introduction

Yun Taek Jung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of antibiotics and the development of novel drug formulations. With a total of 6 patents to his name, his work continues to impact the industry positively.

Latest Patents

One of his latest patents is the "Process of purifying vancomycin hydrochloride." This patent provides a method for purifying vancomycin from a fermentation broth of a microorganism containing vancomycin. The process includes passing the fermentation broth through a strong acid cation exchange resin, a weak base anion exchange resin, alumina, and a hydrophobic absorbent resin sequentially. Another notable patent is the "Crystalline organic acid salt of amlodipine." This invention presents a novel crystalline organic acid salt of amlodipine that has improved physiochemical properties, along with a preparation method and a pharmaceutical composition comprising the same.

Career Highlights

Yun Taek Jung is associated with CJ Corporation, a leading company in the food and biotechnology sectors. His work at CJ Corporation has allowed him to focus on innovative solutions in drug development and purification processes.

Collaborations

He has collaborated with notable colleagues, including Dong Kwon Lim and Hyuk Koo Lee, to advance his research and patent applications.

Conclusion

Yun Taek Jung's contributions to pharmaceutical innovations demonstrate his expertise and commitment to improving drug formulations and purification methods. His patents reflect a dedication to enhancing healthcare solutions through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…